The University of Southampton
University of Southampton Institutional Repository

Activating killer cell immunoglobulin‐like receptors: detection, function and therapeutic use

Activating killer cell immunoglobulin‐like receptors: detection, function and therapeutic use
Activating killer cell immunoglobulin‐like receptors: detection, function and therapeutic use
Killer cell immunoglobulin-like receptors (KIRs) have a central role in the control of natural killer (NK) cell function. The functions of the activating KIRs, as compared to those of the inhibitory KIR, have been more difficult to define due to difficulties in antibody-mediated identification and their apparent low affinities for HLA class I. Immunogenetic studies have shown associations of activating KIRs with the outcome of autoimmune diseases, pregnancy-associated disorders, infectious diseases and cancers. Activating KIR are thus thought to have important roles in the control of natural killer cell functions and their role in disease. In this review, we discuss current knowledge on activating KIR, their ligands and, their roles in the pathogenesis and potential therapy of human diseases.
1744-3121
Blunt, Matthew D.
b1109de3-6045-4bc3-bd77-6cf26504697d
Khakoo, Salim I.
6c16d2f5-ae80-4d9b-9100-6bfb34ad0273
Blunt, Matthew D.
b1109de3-6045-4bc3-bd77-6cf26504697d
Khakoo, Salim I.
6c16d2f5-ae80-4d9b-9100-6bfb34ad0273

Blunt, Matthew D. and Khakoo, Salim I. (2020) Activating killer cell immunoglobulin‐like receptors: detection, function and therapeutic use. International Journal of Immunogenetics, 47 (1). (doi:10.1111/iji.12461).

Record type: Article

Abstract

Killer cell immunoglobulin-like receptors (KIRs) have a central role in the control of natural killer (NK) cell function. The functions of the activating KIRs, as compared to those of the inhibitory KIR, have been more difficult to define due to difficulties in antibody-mediated identification and their apparent low affinities for HLA class I. Immunogenetic studies have shown associations of activating KIRs with the outcome of autoimmune diseases, pregnancy-associated disorders, infectious diseases and cancers. Activating KIR are thus thought to have important roles in the control of natural killer cell functions and their role in disease. In this review, we discuss current knowledge on activating KIR, their ligands and, their roles in the pathogenesis and potential therapy of human diseases.

This record has no associated files available for download.

More information

Accepted/In Press date: 24 October 2019
e-pub ahead of print date: 22 November 2019
Published date: 10 January 2020

Identifiers

Local EPrints ID: 478430
URI: http://eprints.soton.ac.uk/id/eprint/478430
ISSN: 1744-3121
PURE UUID: ad581f22-821f-46ea-9a45-679a32c17162
ORCID for Matthew D. Blunt: ORCID iD orcid.org/0000-0003-1099-3985
ORCID for Salim I. Khakoo: ORCID iD orcid.org/0000-0002-4057-9091

Catalogue record

Date deposited: 30 Jun 2023 16:51
Last modified: 17 Mar 2024 03:32

Export record

Altmetrics

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×